![John D. Weinberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
John D.
Weinberg worked as the Head of Oncology Business Unit at Enzon Pharmaceuticals, Inc. from 2003 to 2005.
He was the SVP of Commercial Operations & Investor Relations at Veloxis Pharmaceuticals A from 2010 to 2012.
He also worked as the Head of Business Franchise at Novartis Pharmaceuticals Corp.
and as the Chief Medical Officer at 4D Pharma Plc.
In 2020, he became the Chief Medical Officer at Maat Pharma SA. Weinberg holds an MBA from INSEAD and a doctorate from the University of the Witwatersrand.
Anciens postes connus de John D. Weinberg
| Sociétés | Poste | Fin |
|---|---|---|
| MAAT PHARMA | Directeur Technique/Scientifique/R&D | 01/06/2022 |
| VELOXIS PHARMACEUTICALS A/S | Directeur des opérations | 29/02/2016 |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 01/01/2005 |
| 4D PHARMA PLC | Directeur Technique/Scientifique/R&D | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Formation de John D. Weinberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
